Patents by Inventor Max KANARSKY
Max KANARSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11724121Abstract: Disorders of the eye can be treated by photobiomodulation therapy according to a device designed to direct light into a patient's eye, no matter the configuration of the eye. The device, including a printed circuit board that includes an array of light delivery devices and a heat sink lens, can be placed proximal to the patient's eye. The light delivery devices can be powered to generate light. The light can be directed into the patient's eye regardless of a position of the patient's eye.Type: GrantFiled: July 23, 2020Date of Patent: August 15, 2023Assignee: MEDICAL QUANT USAInventors: Douglas Johnson, Max Kanarsky, Larry W. Finn, Ian Dwayne Campbell, Jeffrey A. Lenk, Michael T. Barrett, Scott R. Lenk
-
Patent number: 11724123Abstract: Photobiomedulation therapy (PBMT) can be applied to the eye to treat optical neuritis, a sign of multiple sclerosis (MS). The light of PBMT can be directed into the eye, regardless of the position of the eye, by a device that includes an array of light delivery devices and a heat sink lens. The device can be placed proximal to the eye to direct the light into the eye. The light can have one or more wavelengths from 400-1100 nm and can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the retina and/or the optic nerve. PBMT applied in this manner provides a noninvasive, safe and effective treatment for optic neuritis.Type: GrantFiled: December 23, 2021Date of Patent: August 15, 2023Assignee: MEDICAL QUANT USAInventors: Douglas Johnson, Max Kanarsky
-
Patent number: 11638833Abstract: Disorders of the eye can be treated by photobiomodulation therapy (PBMT) delivered by a PBMT device. The PBMT device can be configured for placement directly over a patient's eye socket to deliver light into the patient's eye regardless of a position of the patient's eye, while preventing blue light from entering the patient's eye (e.g., due to a filter within the PBMT device and/or an opacity of the housing of the PBMT device). The PBMT device can be powered by a controller.Type: GrantFiled: July 23, 2020Date of Patent: May 2, 2023Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Larry W. Finn, Ian Dwayne Campbell, Jeffrey A. Lenk, Michael T. Barrett, Scott R. Lenk
-
Publication number: 20230089469Abstract: During a period of lack of use, a person risks muscle atrophy and/or otherwise losing muscle strength/functionality. During such a period of lack of user, a photoceutical can be applied to the person’s muscle(s) through a photoceutical medical device to decrease the occurrence of these risks. The photoceutical is specially configured to reduce these risks and includes at least one of a pulsed light signal, a continuous light signal, and a super-pulsed light signal.Type: ApplicationFiled: February 12, 2021Publication date: March 23, 2023Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto Cesar Pinto LEAL JUNIOR
-
Publication number: 20230063704Abstract: Respiratory function can be preserved and/or enhanced in patients with a respiratory insufficiency using a photoceutical applied by a photoceutical medical device to at least one primary inspiratory muscle and/or a lung. At least one site on a body of a patient can be selected for delivery of the photoceutical to the muscle(s); and the photoceutical can be applied at the at least one site by the photoceutical medical device for a time period from a first start time to a first end time to treat the at least one primary inspiratory muscle and/or the lung of the patient to preserve and/or enhance the respiratory function. The photoceutical can include a light signal with at least one delivery scheme (e.g., superpulsed, pulsed. and/or continuous) and one or more wavelengths.Type: ApplicationFiled: October 31, 2022Publication date: March 2, 2023Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto Cesar Pinto LEAL JUNIOR
-
Patent number: 11590355Abstract: Photobiomodulation therapy (PBMT) can be applied to a tender area on a subject's body to treat fibromyalgia. A light source device can be contacted to a subject's skin proximal to a tender area on the subject's body. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the tender area. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the tender area to treat fibromyalgia.Type: GrantFiled: August 13, 2020Date of Patent: February 28, 2023Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Ernesto Leal-Junior
-
Patent number: 11426600Abstract: Photobiomodulation therapy (PBMT) can be applied to a dystrophic muscle to delay dystrophy progression. A light source device can be contacted to a subject's skin proximal to a dystrophic muscle or muscle group. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the dystrophic muscle or muscle group. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the dystrophic muscle or muscle group.Type: GrantFiled: April 13, 2018Date of Patent: August 30, 2022Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Ernesto Leal-Junior
-
Publication number: 20220184412Abstract: Photobiomedulation therapy (PBMT) can be applied to the eye to treat optical neuritis, a sign of multiple sclerosis (MS). The light of PBMT can be directed into the eye, regardless of the position of the eye, by a device that includes an array of light delivery devices and a heat sink lens. The device can be placed proximal to the eye to direct the light into the eye. The light can have one or more wavelengths from 400-1100 nm and can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the retina and/or the optic nerve. PBMT applied in this manner provides a noninvasive, safe and effective treatment for optic neuritis.Type: ApplicationFiled: December 23, 2021Publication date: June 16, 2022Inventors: Douglas JOHNSON, Max KANARSKY
-
Patent number: 11253722Abstract: Photobiomedulation therapy (PBMT) can be applied to the eye to treat optical neuritis, a sign of multiple sclerosis (MS). The light of PBMT can be directed into the eye, regardless of the position of the eye, by a device that includes an array of light delivery devices and a heat sink lens. The device can be placed proximal to the eye to direct the light into the eye. The light can have one or more wavelengths from 400-1100 nm and can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the retina and/or the optic nerve. PBMT applied in this manner provides a noninvasive, safe and effective treatment for optic neuritis.Type: GrantFiled: October 30, 2019Date of Patent: February 22, 2022Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky
-
Publication number: 20220001194Abstract: Photobiomodulation therapy (PBMT) can be used to improve functional mobility of stroke survivors. A light source device can be contacted to a subject's skin proximal to an area of hemiplegia within a subject due to the stroke. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the area of hemiplegia. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the area of hemiplegia to improve the functional mobility of the subject.Type: ApplicationFiled: November 4, 2019Publication date: January 6, 2022Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto Cesar Pinto LEAL JUNIOR
-
Patent number: 11179573Abstract: Photobiomodulation therapy (PBMT) provides an effective, non-invasive treatment for urinary incontinence that can be used discretely. A light source device can be contacted to a subject's skin proximal to a subject's bladder. A light signal can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the subject's skin proximal to the subject's bladder. The light signal can be applied for a time sufficient to stimulate a phototherapeutic response in one or more muscles and/or nerves proximal to the bladder to treat urinary incontinence.Type: GrantFiled: March 16, 2021Date of Patent: November 23, 2021Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Ernesto Cesar Pinto Leal-Junior
-
Publication number: 20210308482Abstract: Photobiomedulation therapy (PBMT) can be applied to the eye to treat optical neuritis, a sign of multiple sclerosis (MS). The light of PBMT can be directed into the eye, regardless of the position of the eye, by a device that includes an array of light delivery devices and a heat sink lens. The device can be placed proximal to the eye to direct the light into the eye. The light can have one or more wavelengths from 400-1100 nm and can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the retina and/or the optic nerve. PBMT applied in this manner provides a noninvasive, safe and effective treatment for optic neuritis.Type: ApplicationFiled: October 30, 2019Publication date: October 7, 2021Inventors: Douglas JOHNSON, Max KANARSKY
-
Publication number: 20210268303Abstract: Photobiomodulation therapy (PBMT) provides an effective, non-invasive treatment for urinary incontinence that can be used discretely. A light source device can be contacted to a subject's skin proximal to a subject's bladder. A light signal can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the subject's skin proximal to the subject's bladder. The light signal can be applied for a time sufficient to stimulate a phototherapeutic response in one or more muscles and/or nerves proximal to the bladder to treat urinary incontinence.Type: ApplicationFiled: March 16, 2021Publication date: September 2, 2021Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto Cesar Pinto LEAL-JUNIOR
-
Patent number: 11077314Abstract: Respiratory function can be preserved in patients requiring mechanical ventilation (MV), such as patients with severe COVID-19, using a photoceutical applied by a photoceutical medical device (including at least one super pulsed laser to provide superpulsed light of a first wavelength, at least two non-coherent light sources to provide light of a second wavelength, and at least two other non-coherent light sources to provide light of a third wavelength) to at least one inspiratory muscle. The photoceutical includes a combination of superpulsed light of the first wavelength, light of the second wavelength, and light of the third wavelength. At least two sites on the body of the patient can be selected and the photoceutical can be delivered: at one of the sites for a first time period; and at another of the sites for a second time period.Type: GrantFiled: January 5, 2021Date of Patent: August 3, 2021Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Ernesto Leal-Junior
-
Publication number: 20200406051Abstract: Photobiomodulation therapy (PBMT) can be applied to a tender area on a subject's body to treat fibromyalgia. A light source device can be contacted to a subject's skin proximal to a tender area on the subject's body. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the tender area. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the tender area to treat fibromyalgia.Type: ApplicationFiled: August 13, 2020Publication date: December 31, 2020Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto LEAL-JUNIOR
-
Publication number: 20200384283Abstract: Photobiomedulation therapy (PBMT) can be applied to a skeletal muscle ameliorate multiple sclerosis (MS). A light source device can be contacted to a subjects skin proximal to the skeletal muscle of a patient affected by MS. A light signal (with one or more wavelengths from 400-1100 nm) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the skeletal muscle and/or a nerve associated with the skeletal muscle. PBMT applied in this manner provides a noninvasive, safe and effective therapy to mitigate muscle weakness and/or muscle fatigue, improve muscle recovery, reduce general fatigue, and maintain muscle strength, thereby increasing quality of life of the patient affected by MS.Type: ApplicationFiled: October 30, 2018Publication date: December 10, 2020Inventors: Douglas JOHNSON, Max KANARSKY
-
Publication number: 20200376291Abstract: Photobiomedulation therapy (PBMT) can be applied to a dystrophic muscle to delay dystrophy progression. A light source device can be contacted to a subject's skin proximal to a dystrophic muscle or muscle group. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the dystrophic muscle or muscle group. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the dystrophic muscle or muscle group.Type: ApplicationFiled: April 13, 2018Publication date: December 3, 2020Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto LEAL-JUNIOR
-
Publication number: 20200353281Abstract: Disorders of the eye can be treated by photobiomodulation therapy according to a device designed to direct light into a patient's eye, no matter the configuration of the eye. The device, including a printed circuit board that includes an array of light delivery devices and a heat sink lens, can be placed proximal to the patient's eye. The light delivery devices can be powered to generate light. The light can be directed into the patient's eye regardless of a position of the patient's eye.Type: ApplicationFiled: July 23, 2020Publication date: November 12, 2020Inventors: Douglas JOHNSON, Max KANARSKY, Larry W. FINN, Ian Dwayne CAMPBELL, Jeffrey A. LENK, Michael T. BARRETT, Scott R. LENK
-
Publication number: 20200353282Abstract: Disorders of the eye can be treated by photobiomodulation therapy (PBMT) delivered by a PBMT device. The PBMT device can be configured for placement directly over a patient's eye socket to deliver light into the patient's eye regardless of a position of the patient's eye, while preventing blue light from entering the patient's eye (e.g., due to a filter within the PBMT device and/or an opacity of the housing of the PBMT device). The PBMT device can be powered by a controller.Type: ApplicationFiled: July 23, 2020Publication date: November 12, 2020Inventors: Douglas JOHNSON, Max KANARSKY, Larry W. FINN, Ian Dwayne CAMPBELL, Jeffrey A. LENK, Michael T. BARRETT, Scott R. LENK
-
Patent number: D910189Type: GrantFiled: February 1, 2019Date of Patent: February 9, 2021Assignee: MULTI RADIANCE MEDICALInventors: Douglas Johnson, Max Kanarsky, Larry W. Finn, Ian Dwayne Campbell, Jeffrey A. Lenk, Michael T. Barrett, Scott R. Lenk